RE: Regional Nodal Irradiation After Breast-Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial

被引：2
|
作者：
Belkacemi, Yazid [1 ,2 ]
Kuten, Abraham [3 ,4 ]
机构：
[1] UPEC, Henri Mondor Univ Hosp, AP HP, Dept Radiat Oncol, Creteil, France
[2] UPEC, Henri Mondor Breast Canc Ctr, INSERM, U955,EQ 07, Creteil, France
[3] Technion Israel Inst Technol, Italian Hosp, Haifa, Israel
[4] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel
来源：
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2018年 / 110卷 / 05期
关键词：
D O I：
10.1093/jnci/djx241
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：539 / 540
页数：2
相关论文
共 50 条
  • [31] Hypofractionated partial breast irradiation after breast-conserving surgery for patients with early stage breast cancer in China Mainland: a single-arm prospective trial
    Zhang, Xiaomeng
    Wang, Xiaofang
    Xu, Zhuohua
    Chu, Yajuan
    Chen, Xingxing
    Zhang, Li
    Meng, Jin
    Shi, Wei
    Yang, Zhaozhi
    Mei, Xin
    Yu, Xiaoli
    Zhang, Zhen
    Guo, Xiaomao
    Mo, Miao
    Liu, Guangyu
    Wu, Jiong
    Shao, Zhimin
    Ma, Jinli
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [32] MammoSite partial breast irradiation following breast-conserving surgery for early-stage breast cancer.
    Shokek, O.
    Yacoub, S.
    Bauer, T. L.
    Bell, T.
    Fortier, G. A.
    Grim, R.
    Hempling, R. E.
    Johnson, D. E.
    Kassas, B.
    Lasher, D.
    Mudge, K.
    Pandelidis, S.
    Pramanik, R.
    Watson, M.
    Wojcicka, J.
    Shah, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
  • [33] Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial
    Vicini, Frank A.
    Cecchini, Reena S.
    White, Julia R.
    Arthur, Douglas W.
    Julian, Thomas B.
    Rabinovitch, Rachel A.
    Kuske, Robert R.
    Ganz, Patricia A.
    Parda, David S.
    Scheier, Michael F.
    Winter, Kathryn A.
    Paik, Soonmyung
    Kuerer, Henry M.
    Vallow, Laura A.
    Pierce, Lori J.
    Mamounas, Eleftherios P.
    McCormick, Beryl
    Costantino, Joseph P.
    Bear, Harry D.
    Germain, Isabelle
    Gustafson, Gregory
    Grossheim, Linda
    Petersen, Ivy A.
    Hudes, Richard S.
    Curran, Walter J., Jr.
    Bryant, John L.
    Wolmark, Norman
    LANCET, 2019, 394 (10215): : 2155 - 2164
  • [34] Suboptimal therapy following breast conserving surgery in triple-negative and HER2-positive breast cancer patients
    Jeffrey E. Johnson
    Paula D. Strassle
    Guilherme C. de Oliveira
    Chris B. Agala
    Philip Spanheimer
    Kristalyn Gallagher
    David Ollila
    Hyman Muss
    Stephanie Downs-Canner
    Breast Cancer Research and Treatment, 2021, 189 : 509 - 520
  • [35] Comparison of neoadjuvant single-agent treatment and dual-HER2 blockade for breast-conserving surgery conversion in HER2-positive breast cancer: a meta-analysis
    Cui, Manlu
    Fu, Juan
    Li, Qiuyun
    BMC CANCER, 2024, 24 (01)
  • [36] BREAST-CONSERVING TREATMENT OF EARLY BREAST-CANCER - RESULTS IN A COMMON CLINICAL-TRIAL
    PIRTOLI, L
    BELLEZZA, A
    PEPI, F
    TUCCI, E
    CROCIANI, M
    CRASTOLLA, AM
    FARZAD, M
    BINDI, M
    ACTA ONCOLOGICA, 1993, 32 (06) : 647 - 651
  • [37] Long-term Results of Breast-conserving Surgery and Radiation Therapy in Early Breast Cancer
    Kim, Jin Hee
    Byun, Sang Jun
    RADIATION ONCOLOGY JOURNAL, 2009, 27 (03): : 153 - 162
  • [38] Dual HER2-blockade with pertuzumab and trastuzumab in HER2-positive early breast cancer: A subanalysis of data from the randomized phase III GeparSepto trial
    Loibl, S.
    Jackisch, J.
    Schneeweiss, A.
    Schmatloch, S.
    Aktas, B.
    Denkert, C.
    Schem, C.
    Wiebringhaus, H.
    Kuemmel, S.
    Luebbe, K.
    Warm, M.
    Just, M.
    Hanusch, C.
    Hackmann, J.
    Blohmer, J-U
    Clemens, M.
    Engels, K.
    Nekljudova, V.
    von Minckwitz, G.
    Untch, M.
    CANCER RESEARCH, 2017, 77
  • [39] Dual HER2-blockade with pertuzumab and trastuzumab in HER2-positive early breast cancer: a subanalysis of data from the randomized phase III GeparSepto trial
    Loibl, S.
    Jackisch, C.
    Schneeweiss, A.
    Schmatloch, S.
    Aktas, B.
    Denkert, C.
    Wiebringhaus, H.
    Kuemmel, S.
    Warm, M.
    Paepke, S.
    Just, M.
    Hanusch, C.
    Hackmann, J.
    Blohmer, J. -U.
    Clemens, M.
    Costa, S. Dan
    Gerber, B.
    Engels, K.
    Nekljudova, V.
    von Minckwitz, G.
    Untch, M.
    ANNALS OF ONCOLOGY, 2017, 28 (03) : 497 - 504
  • [40] Breast-conserving surgery plus hormone therapy without irradiation in elderly women with early breast cancer
    Inoue, H.
    Hirano, A.
    Ogura, K.
    Hattori, A.
    Yukawa, H.
    Sakaguchi, S.
    Matsuoka, A.
    Tanaka, N.
    Kodera, A.
    Kamimura, M.
    Fujibayashi, M.
    Naritaka, Y.
    Shimizu, T.
    CANCER RESEARCH, 2017, 77
12345